{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:05:20Z","timestamp":1761491120286,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00284-020-02297-5","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T11:04:21Z","timestamp":1610017461000},"page":"718-726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Inflammatory and Fibrotic Patterns of Hepatic Stellate Cells Following Coagulation Factors (VII or X)-Shielded Adenovirus Infection"],"prefix":"10.1007","volume":"78","author":[{"given":"Alireza","family":"Shiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Sarvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Firoozi Ghahestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Gholijani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Mohammad","family":"Tamaddon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahroo","family":"Rastegari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afagh","family":"Moattari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5881-6796","authenticated-orcid":false,"given":"Seyed Younes","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"2297_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-016-0158-5","volume":"4","author":"H Rehman","year":"2016","unstructured":"Rehman H, Silk AW, Kane MP, Kaufman HL (2016) Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy. J Immunother Cancer 4:53. https:\/\/doi.org\/10.1186\/s40425-016-0158-5","journal-title":"J Immunother Cancer"},{"key":"2297_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40257-016-0238-9","volume":"18","author":"PK Bommareddy","year":"2017","unstructured":"Bommareddy PK, Patel A, Hossain S, Kaufman HL (2017) Talimogene laherparepvec (T-VEC) and other oncolytic viruses for the treatment of melanoma. Am J Clin Dermatol 18:1\u201315. https:\/\/doi.org\/10.1007\/s40257-016-0238-9","journal-title":"Am J Clin Dermatol"},{"key":"2297_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0298-180","volume":"18","author":"G Schiedner","year":"1998","unstructured":"Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S (1998) Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18:180. https:\/\/doi.org\/10.1038\/ng0298-180","journal-title":"Nat Genet"},{"key":"2297_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/1566523213666131125095046","volume":"13","author":"WS Wold","year":"2013","unstructured":"Wold WS, Toth K (2013) Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther 13:421\u2013433. https:\/\/doi.org\/10.2174\/1566523213666131125095046","journal-title":"Curr Gene Ther"},{"key":"2297_CR5","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/blood-2009-12-260026","volume":"116","author":"R Alba","year":"2010","unstructured":"Alba R, Bradshaw AC, Coughlan L, Denby L, McDonald RA, Waddington SN, Buckley SMK, Greig JA, Parker AL, Miller AM, Wang H, Lieber A, van Rooijen N, McVey JH, Nicklin SA, Baker AH (2010) Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors. Blood 116:2656\u20132664. https:\/\/doi.org\/10.1182\/blood-2009-12-260026","journal-title":"Blood"},{"key":"2297_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/B978-0-12-800276-6.00014-0","volume-title":"Adenoviral vectors for gene therapy","author":"S Atasheva","year":"2016","unstructured":"Atasheva S, Shayakhmetov DM (2016) 14\u2014innate immune response to adenovirus vector administration in vivo. In: Curiel DT (ed) Adenoviral vectors for gene therapy, 2nd edn. Academic Press, San Diego, pp 349\u2013366. https:\/\/doi.org\/10.1016\/B978-0-12-800276-6.00014-0","edition":"2"},{"key":"2297_CR7","doi-asserted-by":"publisher","unstructured":"Ponterio E, Gnessi L (2015) Adenovirus 36 and obesity: an overview. Viruses 7(7). https:\/\/doi.org\/10.3390\/v7072787","DOI":"10.3390\/v7072787"},{"key":"2297_CR8","doi-asserted-by":"publisher","unstructured":"Chu RL, Post DE, Khuri FR, Van Meir EG (2004) Use of replicating oncolytic adenoviruses in combination therapy for cancer. Clin Cancer Res 10 (16):5299\u20135312. https:\/\/ doi:https:\/\/doi.org\/10.1158\/1078-0432.ccr-0349-03","DOI":"10.1158\/1078-0432.ccr-0349-03"},{"key":"2297_CR9","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/sj.cgt.7700928","volume":"13","author":"JN Glasgow","year":"2006","unstructured":"Glasgow JN, Everts M, Curiel DT (2006) Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 13:830. https:\/\/doi.org\/10.1038\/sj.cgt.7700928","journal-title":"Cancer Gene Ther"},{"key":"2297_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/gt.2011.87","volume":"19","author":"R Alba","year":"2012","unstructured":"Alba R, Bradshaw AC, Mestre-Franc\u00e9s N, Verdier J-M, Henaff D, Baker AH (2012) Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus). Gene Ther 19:109\u2013113. https:\/\/doi.org\/10.1038\/gt.2011.87","journal-title":"Gene Ther"},{"key":"2297_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/gt.2016.32","volume":"23","author":"MR Duffy","year":"2016","unstructured":"Duffy MR, Doszpoly A, Turner G, Nicklin SA, Baker AH (2016) The relevance of coagulation factor X protection of adenoviruses in human sera. Gene Ther 23:592. https:\/\/doi.org\/10.1038\/gt.2016.32","journal-title":"Gene Ther"},{"key":"2297_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1126\/science.1226625","volume":"338","author":"K Doronin","year":"2012","unstructured":"Doronin K, Flatt JW, Di Paolo NC, Khare R, Kalyuzhniy O, Acchione M, Sumida JP, Ohto U, Shimizu T, Akashi-Takamura S, Miyake K, MacDonald JW, Bammler TK, Beyer RP, Farin FM, Stewart PL, Shayakhmetov DM (2012) Coagulation factor X activates innate immunity to human species C adenovirus. Science 338:795\u2013798. https:\/\/doi.org\/10.1126\/science.1226625","journal-title":"Science"},{"issue":"3","key":"2297_CR13","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.biopha.2012.10.002","volume":"67","author":"D Kong","year":"2013","unstructured":"Kong D, Zhang F, Zhang Z, Lu Y, Zheng S (2013) Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential. Biomed Pharmacother 67(3):246\u2013250. https:\/\/doi.org\/10.1016\/j.biopha.2012.10.002","journal-title":"Biomed Pharmacother"},{"key":"2297_CR14","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/s0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL (2003) Liver fibrosis\u2014from bench to bedside. J Hepatol 38:S38\u2013S53. https:\/\/doi.org\/10.1016\/s0168-8278(02)00429-4","journal-title":"J Hepatol"},{"key":"2297_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-0037-1601350","volume":"37","author":"F Alegre","year":"2017","unstructured":"Alegre F, Pelegrin P, Feldstein AE (2017) Inflammasomes in liver fibrosis. Semin Liver Dis 37:119\u2013127. https:\/\/doi.org\/10.1055\/s-0037-1601350","journal-title":"Semin Liver Dis"},{"key":"2297_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12668-016-0378-7","volume":"7","author":"A Shafigullina","year":"2017","unstructured":"Shafigullina A, Zaikina E, Garanina E, Sakhapov D, Titova A, Mavlikeev M, Rizvanov A, Gumerova A, Kiassov A (2017) Effect of adenoviral transduction of hepatic stellate cells with Adv5-optHGF-RFP on their phenotype. Bionanoscience 7:419\u2013422. https:\/\/doi.org\/10.1007\/s12668-016-0378-7","journal-title":"Bionanoscience"},{"key":"2297_CR17","doi-asserted-by":"publisher","first-page":"e67091","DOI":"10.1371\/journal.pone.0067091","volume":"8","author":"J Reetz","year":"2013","unstructured":"Reetz J, Genz B, Meier C, Kowtharapu BS, Timm F, Vollmar B, Herchenroder O, Abshagen K, Putzer BM (2013) Development of adenoviral delivery systems to target hepatic stellate cells in vivo. PLoS One 8:e67091. https:\/\/doi.org\/10.1371\/journal.pone.0067091","journal-title":"PLoS One"},{"key":"2297_CR18","doi-asserted-by":"publisher","first-page":"e6130","DOI":"10.5812\/hepatmon.6130","volume":"12","author":"SY Hosseini","year":"2012","unstructured":"Hosseini SY, Sabahi F, Moazzeni SM, Modarressi MH, Saberi Firoozi M, Ravanshad M (2012) Construction and preparation of three recombinant adenoviruses expressing truncated NS3 and core genes of hepatitis C virus for vaccine purposes. Hepat Mon 12:e6130. https:\/\/doi.org\/10.5812\/hepatmon.6130","journal-title":"Hepat Mon"},{"issue":"2","key":"2297_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0166-0934(01)00316-0","volume":"96","author":"DD LaBarre","year":"2001","unstructured":"LaBarre DD, Lowy RJ (2001) Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays. J Virol Methods 96(2):107\u2013126. https:\/\/doi.org\/10.1016\/S0166-0934(01)00316-0","journal-title":"J Virol Methods"},{"key":"2297_CR20","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1158\/0008-5472.can-14-3761","volume":"75","author":"A Browne","year":"2015","unstructured":"Browne A, Tookman LA, Ingemarsdotter CK, Bouwman RD, Pirlo K, Wang Y, McNeish IA, Lockley M (2015) Pharmacological inhibition of \u03b23 integrin reduces the inflammatory toxicities caused by oncolytic adenovirus without compromising anticancer activity. Cancer Res 75:2811\u20132821. https:\/\/doi.org\/10.1158\/0008-5472.can-14-3761","journal-title":"Cancer Res"},{"issue":"3","key":"2297_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5114\/ceh.2020.99512","volume":"6","author":"SF Ghahestani","year":"2020","unstructured":"Ghahestani SF, Shiri A, Moattari A, Sarvari J, Tamaddon AM, Hosseini SY (2020) The superior role of coagulation factor FX over FVII in adenoviral-mediated innate immune induction of the hepatocyte: an in vitro experiment. Clin Exp Hepatol 6(3):199\u2013206. https:\/\/doi.org\/10.5114\/ceh.2020.99512","journal-title":"Clin Exp Hepatol"},{"key":"2297_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.gt.3302347","volume":"12","author":"AN Varnavski","year":"2005","unstructured":"Varnavski AN, Calcedo R, Bove M, Gao G, Wilson JM (2005) Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-na\u00efve and pre-immunized mice. Gene Ther 12:427. https:\/\/doi.org\/10.1038\/sj.gt.3302347","journal-title":"Gene Ther"},{"key":"2297_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/fvl.11.6","volume":"6","author":"SM Gregory","year":"2011","unstructured":"Gregory SM, Nazir SA, Metcalf JP (2011) Implications of the innate immune response to adenovirus and adenoviral vectors. Future Virol 6:357\u2013374. https:\/\/doi.org\/10.2217\/fvl.11.6","journal-title":"Future Virol"},{"key":"2297_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.virol.2018.04.005","volume":"519","author":"P Li","year":"2018","unstructured":"Li P, Feng F, Pan E, Fan X, Yang Q, Guan M, Chen L, Sun C (2018) Scavenger receptor-mediated Ad5 entry and acLDL accumulation in monocytes\/macrophages synergistically trigger innate responses against viral infection. Virology 519:86\u201398. https:\/\/doi.org\/10.1016\/j.virol.2018.04.005","journal-title":"Virology"},{"key":"2297_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/2193-1801-2-234","volume":"2","author":"M Schulte","year":"2013","unstructured":"Schulte M, Sorkin M, Al-Benna S, Stupka J, Hirsch T, Daigeler A, Kesting MR, Steinau H-U, Jacobsen F, Steinstraesser L (2013) Innate immune response after adenoviral gene delivery into skin is mediated by AIM2, NALP3, DAI and mda5. Springerplus 2:234. https:\/\/doi.org\/10.1186\/2193-1801-2-234","journal-title":"Springerplus"},{"key":"2297_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jconrel.2016.06.022","volume":"235","author":"L Krutzke","year":"2016","unstructured":"Krutzke L, Prill JM, Engler T, Schmidt CQ, Xu Z, Byrnes AP, Simmet T, Kreppel F (2016) Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: preventing vector clearance and preserving infectivity. J Control Release 235:379\u2013392. https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.022","journal-title":"J Control Release"},{"key":"2297_CR27","doi-asserted-by":"publisher","first-page":"9610","DOI":"10.1128\/JVI.01070-13","volume":"87","author":"EE Irons","year":"2013","unstructured":"Irons EE, Flatt JW, Doronin K, Fox TL, Acchione M, Stewart PL, Shayakhmetov DM (2013) Coagulation factor binding orientation and dimerization may influence infectivity of adenovirus-coagulation factor complexes. J Virol 87:9610\u20139619. https:\/\/doi.org\/10.1128\/JVI.01070-13","journal-title":"J Virol"},{"key":"2297_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/rmv.612","volume":"19","author":"N Arnberg","year":"2009","unstructured":"Arnberg N (2009) Adenovirus receptors: implications for tropism, treatment and targeting. Rev Med Virol 19:165\u2013178. https:\/\/doi.org\/10.1002\/rmv.612","journal-title":"Rev Med Virol"},{"key":"2297_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/hum.2014.001","volume":"25","author":"R Hendrickx","year":"2014","unstructured":"Hendrickx R, Stichling N, Koelen J, Kuryk L, Lipiec A, Greber UF (2014) Innate immunity to adenovirus. Hum Gene Ther 25:265\u2013284. https:\/\/doi.org\/10.1089\/hum.2014.001","journal-title":"Hum Gene Ther"},{"key":"2297_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jmb.2008.05.056","volume":"381","author":"PA Lemaire","year":"2008","unstructured":"Lemaire PA, Anderson E, Lary J, Cole JL (2008) Mechanism of PKR activation by dsRNA. J Mol Biol 381:351\u2013360. https:\/\/doi.org\/10.1016\/j.jmb.2008.05.056","journal-title":"J Mol Biol"},{"key":"2297_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tibs.2006.12.003","volume":"32","author":"JL Cole","year":"2007","unstructured":"Cole JL (2007) Activation of PKR: an open and shut case? Trends Biochem Sci 32:57\u201362. https:\/\/doi.org\/10.1016\/j.tibs.2006.12.003","journal-title":"Trends Biochem Sci"},{"key":"2297_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.febslet.2015.05.006","volume":"589","author":"A Dalet","year":"2015","unstructured":"Dalet A, Gatti E, Pierre P (2015) Integration of PKR-dependent translation inhibition with innate immunity is required for a coordinated anti-viral response. FEBS Lett 589:1539\u20131545. https:\/\/doi.org\/10.1016\/j.febslet.2015.05.006","journal-title":"FEBS Lett"},{"key":"2297_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.imlet.2010.09.003","volume":"134","author":"BH Lee","year":"2010","unstructured":"Lee BH, Kushwah R, Wu J, Ng P, Palaniyar N, Grinstein S, Philpott DJ, Hu J (2010) Adenoviral vectors stimulate innate immune responses in macrophages through cross-talk with epithelial cells. Immunol Lett 134:93\u2013102. https:\/\/doi.org\/10.1016\/j.imlet.2010.09.003","journal-title":"Immunol Lett"},{"key":"2297_CR34","doi-asserted-by":"publisher","first-page":"e116142","DOI":"10.1371\/journal.pone.0116142","volume":"9","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Chen T, Bozkanat M, Ibe JCF, Christman JW, Raj JU, Zhou G (2015) Intratracheal instillation of high dose adenoviral vectors is sufficient to induce lung injury and fibrosis in mice. PLoS One 9:e116142. https:\/\/doi.org\/10.1371\/journal.pone.0116142","journal-title":"PLoS One"},{"key":"2297_CR35","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1128\/jvi.03576-14","volume":"89","author":"K Eichholz","year":"2015","unstructured":"Eichholz K, Mennechet FJD, Kremer EJ (2015) Human coagulation factor X-adenovirus type 5 complexes poorly stimulate an innate immune response in human mononuclear phagocytes. J Virol 89:2884. https:\/\/doi.org\/10.1128\/jvi.03576-14","journal-title":"J Virol"},{"key":"2297_CR36","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jhbp.245","volume":"22","author":"E Seki","year":"2015","unstructured":"Seki E, Brenner DA (2015) Recent advancement of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat Sci 22:512\u2013518. https:\/\/doi.org\/10.1002\/jhbp.245","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2297_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3892\/ijmm.2018.3600","volume":"42","author":"H Zhang","year":"2018","unstructured":"Zhang H, Ju B, Nie Y, Song B, Xu Y, Gao P (2018) Adenovirusmediated knockdown of activin A receptor type 2A attenuates immuneinduced hepatic fibrosis in mice and inhibits interleukin17induced activation of primary hepatic stellate cells. Int J Mol Med 42:279\u2013289. https:\/\/doi.org\/10.3892\/ijmm.2018.3600","journal-title":"Int J Mol Med"},{"key":"2297_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3978\/j.issn.2304-3881.2014.11.03","volume":"3","author":"R Weiskirchen","year":"2014","unstructured":"Weiskirchen R, Tacke F (2014) Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr 3:344\u2013363. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2014.11.03","journal-title":"Hepatobiliary Surg Nutr"},{"key":"2297_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1476-9255-9-49","volume":"9","author":"SG Boaru","year":"2012","unstructured":"Boaru SG, Borkham-Kamphorst E, Tihaa L, Haas U, Weiskirchen R (2012) Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease. J Inflamm (Lond) 9:49. https:\/\/doi.org\/10.1186\/1476-9255-9-49","journal-title":"J Inflamm (Lond)"},{"key":"2297_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.virol.2004.06.043","volume":"328","author":"H Engler","year":"2004","unstructured":"Engler H, Machemer T, Philopena J, Wen S-F, Quijano E, Ramachandra M, Tsai V, Ralston R (2004) Acute hepatotoxicity of oncolytic adenoviruses in mouse models is associated with expression of wild-type E1a and induction of TNF-\u03b1. Virology 328:52\u201361. https:\/\/doi.org\/10.1016\/j.virol.2004.06.043","journal-title":"Virology"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-020-02297-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00284-020-02297-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-020-02297-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T23:02:47Z","timestamp":1612825367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00284-020-02297-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2297"],"URL":"https:\/\/doi.org\/10.1007\/s00284-020-02297-5","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"type":"print","value":"0343-8651"},{"type":"electronic","value":"1432-0991"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"7 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}